Barclays PLC Amgen Inc Call Options Transaction History

Barclays PLC

$377 Billion
Q3 2024

Call Options

22 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$309.38 - $337.38 $161 Million - $175 Million	-519,200 Reduced 86.82%	78,800 $25.4 Million
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $105 Million - $128 Million	399,500 Added 201.26%	598,000 $187 Million
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $18.9 Million - $22.8 Million	70,200 Added 54.72%	198,500 $56.4 Million
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $2.58 Million - $2.91 Million	10,100 Added 8.54%	128,300 $37 Million
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $7.61 Million - $9.45 Million	34,800 Added 41.73%	118,200 $31.8 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $10.8 Million - $12.7 Million	50,200 Added 151.2%	83,400 $18.5 Million
Q1 2023 May 04, 2023	SELL	$225.79 - $275.2 $6.86 Million - $8.37 Million	-30,400 Reduced 47.8%	33,200 $8.03 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $14.6 Million - $18.5 Million	63,600 New	63,600 $16.7 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $9.16 Million - $10.2 Million	39,200 Added 196.0%	59,200 $14.4 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $2.09 Million - $2.43 Million	-9,400 Reduced 31.97%	20,000 $4.98 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $3.57 Million - $4.25 Million	-16,500 Reduced 35.95%	29,400 $6.76 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $17.8 Million - $23.6 Million	-97,800 Reduced 68.06%	45,900 $9.31 Million
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $22.1 Million - $28.5 Million	-117,000 Reduced 44.88%	143,700 $34.6 Million
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $38.3 Million - $45.9 Million	-219,800 Reduced 45.74%	260,700 $50.4 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $68.3 Million - $80.1 Million	410,000 Added 581.56%	480,500 $88.5 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $3.87 Million - $4.36 Million	-21,400 Reduced 23.29%	70,500 $13.4 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $9.85 Million - $11.5 Million	-55,200 Reduced 37.53%	91,900 $17.9 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $3.63 Million - $4.09 Million	-19,600 Reduced 11.76%	147,100 $30.5 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $5.31 Million - $5.97 Million	32,000 Added 23.76%	166,700 $30.8 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $4.18 Million - $4.89 Million	-24,700 Reduced 15.5%	134,700 $23 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $16.2 Million - $18.1 Million	-95,900 Reduced 37.56%	159,400 $27.7 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $42.7 Million - $48.8 Million	255,300	255,300 $47.6 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account